Tag Archives: Federal Circuit En Banc
Supreme Court Patent Update: 271(e) Safe Harbor
by Dennis Crouch
Look for opinions in Halo/Stryker and Cuozzo by the end June 2016.
Post Grant Admin: While we await Cuozzo, a set of follow-on cases continue to pile-up. My speculation is that the Supreme Court will delay any decision in those cases until it finalizes the outcome of Cuozzo. With a host of new friend-of-the-court briefs and interesting constitutional questions, MCM v. HP is perhaps best positioned for certiorari. Additional pending cases include Versata v. SAP (scope of CBM review); Cooper v. Lee (whether IPRs violate Separation of Powers); Click-to-Call Tech, LP v. Oracle Corp., (Same questions as Cuozzo and now-dismissed Achates v. Apple); GEA Process Engineering, Inc. v. Steuben Foods, Inc. (Flip-side of Cuozzo: Appeal when PTAB exceeds its authority by terminating an instituted IPR proceeding?); Interval Licensing LLC v. Lee (Same as Cuozzo); and Stephenson v. Game Show Network, LLC (Same as Cuozzo)
Design Patent Damages: Samsung has filed its opening merits briefs in the design patent damages case against Apple. Design patent infringement leads to profit disgorgment, but the question is what profits? [More from Patently-O].
Versus Cisco: There are a couple of newly filed petitions. Interestingly, both filed by Michael Heim's firm with Miranda Jones on both briefs representing plaintiff-petitioners. In both cases Cisco is respondent.
- CSIRO v. CISCO (fact-law divide in proving infringement damages under 35 U.S.C. § 284).
- COMMIL v. CISCO (appellate disregard of factual evidence).
Of course, Commil was the subject to a 2015 Supreme Court decision that rejected the Federal Circuit's original opinion favoring Cisco. On remand, the Federal Circuit completely changed its decision but again sided with Cisco and rejected the jury verdict -- holding "that substantial evidence does not support the jury’s finding that Cisco’s devices, when used, perform the “running” step of the asserted claims."
Safe Harbor for Federal Submissions: In the newly filed Amphastar Pharma case, the Supreme Court has already requested a response from Momenta. The question presented focuses on the safe-harbor provision of 35 U.S.C. § 271(e)(1) and asks: Whether the safe harbor protects a generic drug manufacturer's bioequivalence testing that is performed only as a condition of maintaining FDA approval and is documented in records that must be submitted to the FDA upon request. The federal circuit held that Amphastar's activity in this case was not protected by the safe harbor because it involved information "routinely reported" to the FDA post-approval. [Amphastar Petition]
The big list:
To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.
In re Aqua Products
To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.
Apple v Samsung: Mooting the Injunction
To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.
Pending Supreme Court Patent Cases 2016 (May 18 Update)
by Dennis Crouch
It is now time to begin looking for an opinion in the Halo/Stryker regarding whether the Federal Circuit's test for willful infringement is too rigid. Those cases were argued in February 2016. We can also expect a decision in Cuozzo prior to the end June 2016.
Supplying Components Abroad: The Solicitor General has finally filed its brief in Life Tech v. Promega. The brief supports certiorari -- but only for one of the two questions presented: namely,
whether a supplier can be held liable for providing 'all or a substantial portion of the components of a patented invention' from the United States when the supplier ships for combination abroad only a single commodity component of a multi-component invention
The patent in the case involves a DNA amplification kit used for personal identification. And, although the allegedly infringing kids were made in the UK, one commodity-component (the Taq polymerase) was supplied from the U.S. Focusing on the language of the statute, the Solicitor Generals argues that liability for export of a single component of a multi-component invention "is contrary to Section 271(f)’s text and structure, and it is inconsistent with the presumption against extraterritoriality." Separately, the brief argues that the Federal Circuit was correct in its holding that a party can actively induce itself - thus 271(f)(1) inducement does not require a third party to be induced. [USPromega CVSG Petition].
Post Grant Admin: I previously discussed GEA Process Engineering. That case involves the Flip-side of Cuozzo and asks whether an appeal can follow when the PTAB exceeds its authority by terminating an already instituted IPR proceeding? The respondent (Steuben Foods) had previously waived its right to respond, but the Supreme Court has now requested a response. That move makes certiorari more likely, but the result will depend upon the outcome in Cuozzo.
Attorney Fees: Newegg Inc. v. MacroSolve, Inc., No. 15-1369. Professor Mark Lemley's brief on behalf of Newegg asks that the attorney-fee framework of Octane Fitness actually be implemented. [NewEggPetition]. Although Octane Fitness gives district courts discretion in determining whether to award fees, Newegg argues that the E.D. Texas court improperly applied "a special, heightened burden of proof." The Supreme Court is currently considering the Kirtsaeng attorney fee case for copyright law. That decision may shed some light on the patent cases as well.
A new petition in Automotive Body Parts, No. 15-1314, focuses on a question of civil procedure regarding a clerk's transfer of a design patent case out of E.D.Tx in a manner that violated the local rules. Here, the clerk transferred the case immediately after the judge ordered transfer even though the local rules call for a 21 day delay. The case is rising through a petition for mandamus, but my view is that the petition fails to show why transfer is so harmful (except for the reality that patent plaintiffs are usually given more respect in E.D.Tx.).
The court was scheduled to discuss Cooper v. Lee at its May 12 conference. No action was taken following that conference - lightly suggesting to me that the court is holding judgment until it resolves Cuozzo. Apart from the AIA Trial challenges, most potential life changing case on the docket for patent attorneys is Cubist v. Hospira that focuses on the role of secondary indicia of non-obviousness. As with most Supreme Court patent cases over the past decade, Cubist argues that the Federal Circuit's rules are too restrictive and should instead follow a looser factor-based analysis when considering the issue. In the next couple of weeks, the court will consider the Cubist petition as well as that of Dow v. NOVA (appellate review standard); Vehicle Intelligence (abstract idea); and WesternGeco (damages calculation for 271(f) infringement by exporting components).
Secret Offers to Sell: The Federal Circuit is not slowing down its patent jurisprudence in any way - except for the rash of R.36 affirmances. An important case is Helsinn that focuses on whether the AIA abrogated the rule in Metallizing Engineering.
The big list:
To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.
Guest Post: 35 USC 289—Grant of Certiorari in Samsung v Apple = The Opportunity for a Better-Crafted Standard for Awarding Total profits
To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.
Automatic Assignment of Future Inventions: A Serious Error of Federal Law that Requires Supreme Court Review
To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.
The Recent Federal Circuit Decision in Acorda Therapeutics v. Mylan Pharmaceuticals May Not be the Last Word on Personal Jurisdiction in ANDA Cases
To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.
Guest Post: The AIA, Inter Partes Review, and Takings Law
To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.
Pending Supreme Court Patent Cases 2016 (May 3 Update)
by Dennis Crouch
Laches: The Supreme Court granted SCA's writ of certiorari on the question of whether laches defense applies to block back-damages in patent cases. The Federal Circuit says "yes" while the Supreme Court recently said "no" in a parallel copyright case (Patrella). The Supreme Court decided Patrella 6-3 with Justice Scalia in the majority offering the potential of a tight-split in this case. The court looks to be sitting-on the parallel case of Medinol v. Cordis until SCA is decided.
Copyright on Useful Articles: Although not a patent case, the court also decided to hear a "useful article" copyright case. Star Athletica v. Varsity Brands. The case asks whether the stripes and chevrons found in a cheerleader uniform are sufficiently "separable" from the uniform in order to be copyrightable. The useful article doctrine is generally considered to be setting up a boundary line between the domains of copyright and patent.
More Challenges to USPTO Authority: MCM filed its petition for writ of certiorari directly challenging USPTO authority to conduct inter partes review proceedings with two easy questions:
- Does IPR violate Article III of the Constitution?
- Does IPR violate the Seventh Amendment to the Constitution?
[MCM Petition and Appendix] MCM's brief was filed Tom Goldstein along with Ned Heller. The question for the Supreme Court is whether to extend or contract from its position in Stern v. Marshall, 131 S. Ct. 2594 (2011) where the court held that Article III of the U.S. Constitution prohibits Congress from withdrawing “from judicial
cognizance any matter which, from its nature, is the subject of a suit at the common law, or in equity, or admiralty.” Quoting Murray’s Lessee v. Hoboken Land & Improvement Co., 59 U.S. 272 (1856)).
The brief raises a set of interesting old cases focusing both on the separation of powers and the tradition that patent-revocation for invalidity requires a jury to decide disputed facts.
- Ex Parte Wood & Brundage, 22 U.S. 603 (1824)
- McCormick Harvesting Mach. Co. v. C. Aultman & Co., 169 U.S. 606 (1898)
- Mowry v. Whitney, 81 U.S. 434 (1871)
- Murray’s Lessee v. Hoboken Land & Improvement Co., 59 U.S. 272 (1856)
- Neilson v. Harford, Webster’s Patent Cases 295 (1841)
- Pennock v. Dialogue, 27 U.S. 1 (1829)
- United States v. Am. Bell Tel. Co., 128 U.S. 315 (1888)
Cooper v. Lee raises some parallel issues. Its petition will be considered by the Court in its May 12. [Update: The court has "rescheduled" consideration of Cooper's brief - perhaps awaiting its own determination in Cuozzo.]
Hereby Assign Future Inventions: In Shukh v. Seagate, the petitioner raises the long-brewing question involving the Federal Circuit's interpretation of patent assignments. In particular, the Federal Circuit has ruled - as a matter of federal patent law - that patent rights are assignable before their invention is even contemplated. The petition asks:
[W]hether FilmTec’s "automatic assignment” rule should be overruled because it extinguishes inventors’ constitutional and statutory rights to inventorship and ownership.
In Stanford v. Roche, Justices Breyer, Ginsburg and Sotomayor criticized the Federal Circuit's rule and suggested that the issue should be presented in a future case. The majority expressly noted that its opinion did not decide the issue. [Shukh v. Seagate - Redacted Public Petition]
Disparaging Trademarks: A pair of disparaging trademark cases have also been petitioned: Lee v. Tam ("Slants") and Pro-Football v. Blackhorse ("Redskins"). The Federal Circuit previously held the limit on registering disparaging marks to be an unconstitutional abrogation of the freedom of speech.
The big list:
To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.
Supreme Court to Review (and likely Reject) Laches as a Defense in Patent Infringement Cases
To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.
Federal Circuit Continues Broad Venue Allowance in Patent Cases
To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.
Federal Circuit Rejects Reduced-Deference for AIA-Trial Decisions
To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.
The Gatekeeping Function of Patent Eligibility as Part of a More Complete Understanding of § 101 Principles
To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.
Section 101 – Pivotal Moment for Clarity on Patent Subject Matter Eligibility
To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.
Pending Supreme Court Patent Cases 2016 (April 18 Update)
by Dennis Crouch
Cuozzo: Prof Mann provides his preview of the April 25 oral arguments in Cuozzo v. Lee; and Cuozzo has filed its reply brief. Neither document address my the mootness concern regarding Cuozzo's demand for an ordinary construction of claim terms rather than their broadest reasonable interpretation. As far as I have seen, nothing in the record suggests that a change in claim interpretation standard would alter the PTO's determination.
Following its April 15 Conference, the Supreme Court denied certiorari in a set of cases, including Vermont v. MPHJ; Limelight v. Akamai; Hemopet v. Hill's Pet Nutrition; and Tas v. Beachy. In its April 1 Conference, the Court denied cert in Retirement Capital v. US Bancorp. That case had questioned whether subject matter eligibility under 35 U.S.C. § 101 is a ground specified as a condition for patentability under 35 U.S.C. § 282(b)(2).
The only patent cases surviving the April 15 conference are (1) Interval Licensing v. Lee that asks the same question as Cuozzo: Can the Patent and Trademark Office appropriately apply the "broadest reasonable interpretation" standard in construing patent claims in post-grant validity challenges?; and (2) Medinol v. Cordis that focuses on whether "the equitable defense of laches [may be used to] bar legal claims for damages that are timely under the express terms of the Patent Act." Medinol is conceptually linked to the SCA Hygiene case that also raises the laches issue. The court will consider both cases in its April 22 conference and may likely couple the decision to grant/deny. The court is also scheduled to consider Cloud Satchel (abstract idea eligibility) and Globus Medical (appellate jurisdiction) at Friday's conference. Neither of these cases offer much hope for the respective petitioner.
In Cooper v. Lee, the US Government filed its brief opposing certiorari. The government argues that Cooper's Article III challenge to the IPR system "lack's merit."
[P]atents are quintessential "public rights" whose issuance and cancellation Congress may permissible entrust to a non-Article III tribunal. . . . Pursuant to its constitutional authority to “promote the Progress of Science and useful Arts” by establishing a patent system, Congress created the PTO - an agency with “special expertise in evaluating patent applications.” Kappos v. Hyatt, 132 S. Ct. 1690 (2012). It directed that agency to issue a patent if “it appears that the applicant is entitled to a patent” under standards set by federal law, 35 U.S.C. 131. Patents are accordingly rights that “exist only by virtue of statute.” Sears, Roebuck & Co. v. Stiffel Co., 376 U.S. 225, 229 n.5 (1964). They “dispose of public rights held by the government on behalf of the people.” Teva Pharm. USA, Inc. v. Sandoz, Inc., 135 S. Ct. 831, 849 n.2 (2015) (Thomas, J., dissenting).
The government also argues that the posture of the case lacks merits - in particular that Cooper's collateral challenge to the procedures doesn't work. Cooper has argued that "inter partes review violates Article III of the Constitution by authorizing an Executive Branch agency, rather than a court, to invalidate a previously issued patent."
Daniel Bohnen has filed a brief on behalf of UK's Chartered Institute of Patent Attorneys (CIPA) in support of the Sequenom v. Ariosa petition. The brief argues that the court should look to "maintain international harmonisation in the law of patent-eligibility."[AriosaCIPA]. More briefs in support of the petitioner are expected this week as is Ariosa's opposition brief (if any).
Finally, Nova has filed its opposition in Dow v. Nova and is attempting to refocus attention on the merits of the indefiniteness decision rather than the procedure for reaching that decision. The difference in question presented is interesting:
Dow: Whether factual findings underlying a district court’s determination on the definiteness of a patent claim under the Patent Act, 35 U.S.C. 112, like a district court’s factual findings underlying construction of a patent claim, are subject to appellate review only for clear error or substantial evidence rather than de novo review.
Nova: Whether the court of appeals correctly invalidated Dow’s patent claims as indefinite under 35 U.S.C. § 112.
Explaining its shift of the question, Nova argues that "Dow's petition rests on a false premise that the Federal Circuit refuses to give deference to factual findings" that underlie the definiteness determination. Nova is correct as to the Federal Circuit's position -- the only question here is whether the Supreme Court will order the appellate court to follow its own law in this case. [DowPetition][NovaOpposition]
The big list:
To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.
Judge Dyk’s Concurrence in the Denial of Rehearing En Banc in Sequenom
To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.
Battles between the PTO and Courts
To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.
Adding Fuel to the Bonfire of Patents
To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.
Cardpool: Amending Claims in Reexam after Court Judgment of Invalidity
To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.